{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1284","meta":{"versionId":"18","lastUpdated":"2021-02-02T15:40:26.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-02-02"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1284","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1284"}],"version":"20190315","name":"MonaminaseOxides","title":"Monaminase Oxides","status":"active","experimental":false,"date":"2019-03-15T01:00:14-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for monaminase oxides.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable monaminase oxides.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and concepts that represent components or ingredients.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"312347","display":"Phenelzine 15 MG Oral Tablet"},{"code":"313447","display":"Tranylcypromine 10 MG Oral Tablet"},{"code":"859186","display":"selegiline hydrochloride 5 MG Oral Capsule"},{"code":"859190","display":"selegiline hydrochloride 1.25 MG Disintegrating Oral Tablet"},{"code":"859193","display":"selegiline hydrochloride 5 MG Oral Tablet"},{"code":"865206","display":"24 HR Selegiline 0.25 MG/HR Transdermal System"},{"code":"865210","display":"24 HR Selegiline 0.375 MG/HR Transdermal System"},{"code":"865214","display":"24 HR Selegiline 0.5 MG/HR Transdermal System"}]}]},"expansion":{"identifier":"urn:uuid:98601dc3-87dc-4717-9457-82ef565bb103","timestamp":"2023-12-11T02:31:29-05:00","total":8,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"312347","display":"phenelzine 15 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"313447","display":"tranylcypromine 10 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"859186","display":"selegiline hydrochloride 5 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"859190","display":"selegiline hydrochloride 1.25 MG Disintegrating Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"859193","display":"selegiline hydrochloride 5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"865206","display":"24 HR selegiline 0.25 MG/HR Transdermal System"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"865210","display":"24 HR selegiline 0.375 MG/HR Transdermal System"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"865214","display":"24 HR selegiline 0.5 MG/HR Transdermal System"}]}}